The Role of 3-Dimensional Echocardiography in the Diagnosis and Management of Mitral Valve Disease. Myxomatous Valve Disease.

Wendy Tsang, Benjamin H. Freed, Roberto M. Lang*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

11 Scopus citations

Abstract

Myxomatous mitral valve (MV) disease is a spectrum that ranges from fibroelastic deficiency to Barlow's disease. Diagnosis has been greatly aided by the use of 3-dimensional echocardiography, which improves not only the accuracy of lesion localization but also the quantification of the associated mitral regurgitation. These improvements in turn have altered MV surgical repair techniques and percutaneous interventions.

Original languageEnglish (US)
Pages (from-to)203-215
Number of pages13
JournalCardiology Clinics
Volume31
Issue number2
DOIs
StatePublished - May 2013

Keywords

  • Barlow's disease
  • Fibroelastic deficiency
  • Myxomatous mitral valve disease
  • Three-dimensional echocardiography

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'The Role of 3-Dimensional Echocardiography in the Diagnosis and Management of Mitral Valve Disease. Myxomatous Valve Disease.'. Together they form a unique fingerprint.

Cite this